BioCryst Pharmaceuticals Inc.

10/14/2024 | Press release | Distributed by Public on 10/14/2024 05:04

BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO® (berotralstat)